Altria Group, Inc. Earnings Recaps
Altria shares surged 9.3% post-earnings as the company reported 7.3% adjusted diluted EPS growth and exceeded market expectations with strong smokeable segment income and robust oral nicotine pouch volume gains. The launch and rapid expansion of on! PLUS nationwide, alongside confident commentary on regulatory progress, contributed to the positive investor response.
Key takeaways
- Adjusted diluted EPS grew 7.3% year-over-year for the first quarter.
- Smokeable products segment delivered strong income growth, with Marlboro strengthening its premium positioning.
- The on! nicotine pouch portfolio reported nearly 18% shipment volume growth, driven by on! PLUS national rollout to 100,000 stores.
- Retail share for on! and on! PLUS reached 7.8% of total oral tobacco, down 0.8 points year-over-year but up sequentially.
- Management noted positive regulatory momentum, with on! PLUS being the first pouch authorized under FDA’s pilot program and additional applications underway.
Altria delivered a solid third quarter with a 3.6% increase in adjusted diluted earnings per share, driven by strong momentum in its smoke-free portfolio. The company continues to expand its nicotine pouch offerings while navigating a competitive landscape.
Key takeaways
- On! nicotine pouches gained 11.1 share points year-over-year, reinforcing Altria's position in the growing oral tobacco category.
- Helix's reported shipment volume grew nearly 1% YoY in Q3, contributing to a 15% increase over the first nine months.
- Altria announced its 60th dividend increase in 56 years and expanded its share repurchase program, highlighting commitment to shareholder returns.
- Regulatory milestones were achieved with the pending FDA approvals for Horizon's heated tobacco products and ongoing developments in the e-vapor space.
- The launch of on! PLUS is expected to enhance market presence with differentiated offerings aimed at both existing customers and competitors' users.
Altria Group reported robust second-quarter performance, driven by significant growth in its on! nicotine pouch segment and a strong return of value to shareholders through dividends and buybacks.
Key takeaways
- On! nicotine pouches experienced a 26.5% increase in shipment volume, capturing over half of the oral tobacco category share.
- Altria returned over $4 billion to shareholders in the first half of 2025 through dividends and share repurchases.
- The company raised the lower end of its 2025 guidance range, indicating confidence in sustained business momentum.
- Regulatory enforcement against illicit e-vapor products is reportedly increasing, which may benefit the controlled market landscape.
- Altria is actively developing NJOY products to align with evolving consumer preferences despite recent challenges in patent litigation.